Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21051321rdf:typepubmed:Citationlld:pubmed
pubmed-article:21051321lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:21051321lifeskim:mentionsumls-concept:C0521390lld:lifeskim
pubmed-article:21051321lifeskim:mentionsumls-concept:C0042444lld:lifeskim
pubmed-article:21051321lifeskim:mentionsumls-concept:C0006050lld:lifeskim
pubmed-article:21051321lifeskim:mentionsumls-concept:C0011209lld:lifeskim
pubmed-article:21051321lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:21051321lifeskim:mentionsumls-concept:C0439539lld:lifeskim
pubmed-article:21051321pubmed:issue3lld:pubmed
pubmed-article:21051321pubmed:dateCreated2011-2-15lld:pubmed
pubmed-article:21051321pubmed:abstractTextThe long half-life of botulinum neurotoxin serotype A (BoNT/A) in cells poses a challenge in developing post-exposure therapeutics complementary to existing antitoxin strategies. Delivery vehicles consisting of the toxin heavy chain (HC), including the receptor-binding domain and translocation domain, connected to an inhibitory cargo offer a possible solution for rescuing intoxicated neurons in victims paralyzed from botulism. Here, we report the expression and purification of soluble recombinant prototype green fluorescent protein (GFP) cargo proteins fused to the entire BoNT/A-HC (residues 544-1295) in Escherichia coli with up to a 40 amino acid linker inserted between the cargo and BoNT/A-HC vehicle. We show that these GFP-HC fusion proteins are functionally active and readily taken up by cultured neuronal cells as well as by neuronal cells in mouse motor nerve endings.lld:pubmed
pubmed-article:21051321pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21051321pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21051321pubmed:languageenglld:pubmed
pubmed-article:21051321pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21051321pubmed:citationSubsetIMlld:pubmed
pubmed-article:21051321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21051321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21051321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21051321pubmed:statusMEDLINElld:pubmed
pubmed-article:21051321pubmed:monthMarlld:pubmed
pubmed-article:21051321pubmed:issn1741-0134lld:pubmed
pubmed-article:21051321pubmed:authorpubmed-author:McArdleJoseph...lld:pubmed
pubmed-article:21051321pubmed:authorpubmed-author:WilsonBrenda...lld:pubmed
pubmed-article:21051321pubmed:authorpubmed-author:ChangLi-HsinL...lld:pubmed
pubmed-article:21051321pubmed:authorpubmed-author:ThyagarajanBa...lld:pubmed
pubmed-article:21051321pubmed:authorpubmed-author:Pires-AlvesMe...lld:pubmed
pubmed-article:21051321pubmed:authorpubmed-author:JohnsonSteven...lld:pubmed
pubmed-article:21051321pubmed:authorpubmed-author:HoMengfeiMlld:pubmed
pubmed-article:21051321pubmed:authorpubmed-author:GuZhengrongZlld:pubmed
pubmed-article:21051321pubmed:authorpubmed-author:BannaiYukaYlld:pubmed
pubmed-article:21051321pubmed:authorpubmed-author:AberleKarla...lld:pubmed
pubmed-article:21051321pubmed:authorpubmed-author:BloomJordan...lld:pubmed
pubmed-article:21051321pubmed:authorpubmed-author:TeymorianSash...lld:pubmed
pubmed-article:21051321pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21051321pubmed:volume24lld:pubmed
pubmed-article:21051321pubmed:ownerNLMlld:pubmed
pubmed-article:21051321pubmed:authorsCompleteYlld:pubmed
pubmed-article:21051321pubmed:pagination247-53lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:meshHeadingpubmed-meshheading:21051321...lld:pubmed
pubmed-article:21051321pubmed:year2011lld:pubmed
pubmed-article:21051321pubmed:articleTitleRecombinant botulinum neurotoxin A heavy chain-based delivery vehicles for neuronal cell targeting.lld:pubmed
pubmed-article:21051321pubmed:affiliationDepartment of Microbiology, University of Illinois at Urbana-Champaign, Champaign, IL, USA.lld:pubmed
pubmed-article:21051321pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21051321pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:21051321pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21051321pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:21051321lld:pubmed